Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Restart Life Sciences (NMLSD)
OTHER OTC:NMLSD
Holding NMLSD?
Track your performance easily
NMLSD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.10
Previous Close$0.01
Volume1.13K
Average Volume (3M)5.00K
Market Cap
$850.77K
Enterprise Value$842.11K
Total Cash (Recent Filing)C$12.06K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Nov 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding29,663,732
10 Day Avg. Volume9,234
30 Day Avg. Volume5,003
Standard Deviation0.39
R-Squared0.00002
Alpha-0.00672
Financial Highlights & Ratios
Price to Book (P/B)-0.35
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-30.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
NMLSD FAQ
What was Restart Life Sciences’s price range in the past 12 months?
Restart Life Sciences lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.
What is Restart Life Sciences’s market cap?
Currently, no data Available
When is Restart Life Sciences’s upcoming earnings report date?
Restart Life Sciences’s upcoming earnings report date is Nov 26, 2024 which is in 12 days.
How were Restart Life Sciences’s earnings last quarter?
Restart Life Sciences released its earnings results on Aug 26, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Restart Life Sciences overvalued?
According to Wall Street analysts Restart Life Sciences’s price is currently Overvalued.
Does Restart Life Sciences pay dividends?
Restart Life Sciences does not currently pay dividends.
What is Restart Life Sciences’s EPS estimate?
Restart Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Restart Life Sciences have?
Restart Life Sciences has 29,663,733 shares outstanding.
What happened to Restart Life Sciences’s price movement after its last earnings report?
Restart Life Sciences reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Restart Life Sciences?
Currently, no hedge funds are holding shares in NMLSD
---
Restart Life Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-90.56%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-58.55%
Trailing 12-Months
Company Description
Restart Life Sciences
Liberty Leaf Holdings Ltd. engages in building and supporting a diversified portfolio of cannabis-sector businesses. It offers cultivation, processing, value-added cannabidiol & pet products, and supply chain products. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---